Polyclonal Antibody News and Research

RSS
SARS-CoV-2 spike mutations during transmission among humans and to animals

SARS-CoV-2 spike mutations during transmission among humans and to animals

NIH to conduct large trial for COVID-19 polyclonal antibody therapies

NIH to conduct large trial for COVID-19 polyclonal antibody therapies

A new polymersome-based SARS-CoV-2 nanovaccine elicits robust immunity

A new polymersome-based SARS-CoV-2 nanovaccine elicits robust immunity

Does natural infection with SARS-CoV-2 offer more protection than a vaccine against new variants?

Does natural infection with SARS-CoV-2 offer more protection than a vaccine against new variants?

Novel polyclonal antibody XAV-19 efficiently neutralizes UK and South African SARS-CoV-2 variants

Novel polyclonal antibody XAV-19 efficiently neutralizes UK and South African SARS-CoV-2 variants

The use of mammalian cell surface display for rapid characterization of SARS-CoV-2 variants

The use of mammalian cell surface display for rapid characterization of SARS-CoV-2 variants

Researchers characterize antibody responses to COVID-19 mRNA-based vaccine

Researchers characterize antibody responses to COVID-19 mRNA-based vaccine

Polyclonal SARS-CoV-2 antibody shows potent neutralizing activity in vitro

Polyclonal SARS-CoV-2 antibody shows potent neutralizing activity in vitro

Urinary shedding of spike protein in COVID-19 patients

Urinary shedding of spike protein in COVID-19 patients

Moderna vaccine fully neutralizes new SARS-CoV-2 variants, study shows

Moderna vaccine fully neutralizes new SARS-CoV-2 variants, study shows

New data on impact of spike mutations and B117 UK variant on neutralization by mAbs and sera

New data on impact of spike mutations and B117 UK variant on neutralization by mAbs and sera

Vimentin could be a major co-factor that aids SARS-CoV-2 infection

Vimentin could be a major co-factor that aids SARS-CoV-2 infection

Neutralization antibodies affected by only a few mutations to the SARS-CoV-2 receptor-binding domain

Neutralization antibodies affected by only a few mutations to the SARS-CoV-2 receptor-binding domain

SARS-CoV-2 D614G mutation does not affect performance of serological assays

SARS-CoV-2 D614G mutation does not affect performance of serological assays

First checkpoint inhibitor vaccine shown to be safe, effective in colon cancer animal model

First checkpoint inhibitor vaccine shown to be safe, effective in colon cancer animal model

Immune-evading variants can emerge in SARS-CoV-2, researchers warn

Immune-evading variants can emerge in SARS-CoV-2, researchers warn

3D imaging of SARS-CoV-2 infection in ferrets using light sheet microscopy

3D imaging of SARS-CoV-2 infection in ferrets using light sheet microscopy

A map of SARS-CoV-2 escape mutations enables the development of therapeutic antibody cocktails

A map of SARS-CoV-2 escape mutations enables the development of therapeutic antibody cocktails

Promising new candidate 'virus-like particle' vaccine for COVID-19

Promising new candidate 'virus-like particle' vaccine for COVID-19

New assay rapidly tests SARS-CoV-2 neutralization and screens antivirals

New assay rapidly tests SARS-CoV-2 neutralization and screens antivirals